Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - magnesium hydroxide; aluminium hydroxide - oral suspension - 200mg/175 mg/5ml - combinations and complexes of aluminium, calcium and magnesium compounds; ordinary salt combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - magnesium hydroxide; aluminium oxide, hydrated - chewable tablet - 400mg/400 milligram(s) - combinations and complexes of aluminium, calcium and magnesium compounds; ordinary salt combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - magnesium carbonate; calcium carbonate - chewable tablet - 680/80 milligram(s) - combinations and complexes of aluminium, calcium and magnesium compounds; ordinary salt combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

opella healthcare france sas t/a sanofi - magnesium hydroxide; aluminium hydroxide - oral suspension - 200mg/175 mg/5ml - combinations and complexes of aluminium, calcium and magnesium compounds; ordinary salt combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

opella healthcare france sas t/a sanofi - magnesium hydroxide; aluminium oxide, hydrated - chewable tablet - 400mg/400 milligram(s) - combinations and complexes of aluminium, calcium and magnesium compounds; ordinary salt combinations

United States - English - NLM (National Library of Medicine)

asm aerosol-service ag - sodium picosulfate (unii: lr57574hn8) (deacetylbisacodyl - unii:r09078e41y), magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - clenpiq is indicated for cleansing of the colon as a preparation for colonoscopy in adults. clenpiq is contraindicated in the following conditions: - patients with severe renal impairment (creatinine clearance less than 30 ml/minute), which may result in accumulation of magnesium [see warnings and precautions (5.3)] - gastrointestinal obstruction or ileus [see warnings and precautions (5.6)] - bowel perforation [see warnings and precautions (5.6)] - toxic colitis or toxic megacolon - gastric retention - hypersensitivity to any of the ingredients in clenpiq risk summary there are no data with clenpiq use in pregnant women to determine a drug-associated risk of adverse developmental outcomes. in animal reproduction studies, no adverse developmental effects were observed in pregnant rats when sodium picosulfate, magnesium oxide, and anhydrous citric acid were administered orally at doses 1.2 times the recommended human dose based on body surface area during organogenesis. the estimated background risk of major

United States - English - NLM (National Library of Medicine)

bath & body works, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - alcohol 68 ml in 100 ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

arpimed llc - aluminium hydroxide, magnesium hydroxide - tablets chewable - 400mg+400mg

Malta - English - Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - magnesium trisilicate, aluminium hydroxide - chewable tablet - magnesium trisilicate 500 mg aluminium hydroxide 250 mg - drugs for acid related disorders

United States - English - NLM (National Library of Medicine)

rochester midland corporation - triclosan (unii: 4nm5039y5x) (triclosan - unii:4nm5039y5x) - antiseptic for hand-washing to decrease bacteria on the skin irritation and redness develop